Replies to post #402037 on Anavex Life Sciences Corp (AVXL)

[Twice Worthy]

In over 38 years Big Pharmas or, biotech companies that focused exclusively on the plaque/tau none have been successful in their treatment of the disease of AD. Even our FDA in desperation to find a meaningful approach to this catastrophic disease approved 2 Biogen drugs that do little to alleviate the significant issues of the disease ... plus their drugs are very expensive, must be given I.V. and must be done by medical personnel ... adding more expense for the treatment .... and the treatment can cause the patient's brain to bleed, which could result in the patient's death. Summed up, just more failures with this dangerous approach.

Am awaiting the approval of Anavex's blarcamesine drug/2 - 73, a safe drug, a pill taken by mouth, that has demonstrated significant results with neuro-degenerative and neuro-developmental diseases affecting the CNS.